Testimony Before the FDA’s Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee Regarding Opioid Analgesics May 4, 2016
Letters to CMS and the Joint Commission Requesting Roll Back of Pain Assessment Requirements That Foster Dangerous Overprescribing of Opioids April 13, 2016
Statement Before the Science Board to the Food and Drug Administration Regarding Opioid Drug Products March 1, 2016
Public Citizen, Partners Petition FDA for Black-Box Warnings on Opioids, Benzodiazepines About Dangers of Concurrent Use February 22, 2016
Comments on the CDC’s Proposed 2016 Guideline for Prescribing Opioids for Chronic Pain January 13, 2016
Comments on the CDC’s Proposed 2016 Guideline for Prescribing Opioids for Chronic Pain January 13, 2016
Coalition Letter to U.S. Senate Finance Committee Calls for Release of Findings of Investigation of Opioid Makers September 16, 2015
Testimony Before the FDA’s Analgesic and Anesthetic Drug Products Advisory Committee Meeting on Moxduo April 22, 2014
Letter to Senator Joe Manchin Urging Him to Investigate FDA’s Decision to Approve Dangerous High-Dose Opioid March 14, 2014